School of Medicine

Sabin Nettles, a graduate student at the School of Medicine, received the Pre/Postdoctoral Next Generation Award from the Society for Neuroscience in recognition of her work introducing neuroscience to young students through the Brain Discovery initiative. 

Washington University School of Medicine is part of a major international study aimed at identifying causes and effects of the early stages of schizophrenia in young people, with the goal of improving early diagnosis and treatment. Daniel Mamah, MD, is the lead investigator at the WashU site.

Jeffrey Zacks, professor in Arts & Sciences and the School of Medicine, will explain how and why television and movies can have such strong effects on our brains in a Mirowitz Center online program Feb. 2.

Laneshia K. Tague, MD, assistant professor of medicine at the School of Medicine, has received the Harold Amos Medical Faculty Development Award.

Elaine M. Majerus, MD, PhD, and Stephen T. Oh, MD, PhD, have been selected to co-lead the Division of Hematology in the Department of Medicine at the School of Medicine.

Ruben G. Nava, MD, and Brian W. Wong, both assistant professors of surgery at the School of Medicine, have been awarded career development grants through the American Society of Transplantation. 

An investigational cancer drug that starves tumors of their energy supply also shows evidence of improving whole body metabolism, according to a new study in mice from Washington University School of Medicine.

A new study from Washington University School of Medicine shows that treatment with an immune-boosting protein called interleukin 7 (IL-7) in combination with radiation improves survival in mice with glioblastoma.

Researchers at the McKelvey School of Engineering and the School of Medicine at Washington University are launching the Women’s Health Technologies Initiative, which will focus on innovative therapies supporting female reproductive health.

An international study involving researchers at Washington University School of Medicine analyzed the risk factors for serious health outcomes in kids who had COVID-19. Researchers found that children up to age 18 who had tested positive for COVID-19 were at low risk for severe health problems.